Impact of HIV on Global Health: A Comprehensive Review of Epidemiology and Interventions

Notice

This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.

Year : 2026 | Volume : 3 | 01 | Page :
    By

    Km Priyanka Singh,

  • Rifat Siraj,

  1. Student, Department of Dental Sciences, Adesh Institute of Dental Science and Research, Adesh University, Bathinda, Punjab, India
  2. Student, Department of Dental Sciences, Adesh Institute of Dental Science and Research, Adesh University, Bathinda, Punjab, India

Abstract

H.I.V remains a significant health issue of great concern to the world and with great impact to the individuals and communities on a global scale. This is a comprehensive literature review on the epidemiology of HIV, including both the world prevalence of HIV and the regional variations, especially in sub-Saharan Africa. It discusses the most important modes of transmission including sexual, blood, and vertical transmission and investigates the effectiveness of prevention measures including behavioral interventions, pre-exposure prophylaxis (PrEP) and the current research on vaccines. The obstacles therein encountered in resource-limited settings and the development of drug resistance are also covered in the review. In addition, it brings out international initiatives to contain HIV such as the 90-90-90 goals and the contribution of technology towards improving HIV care. There are directions in treatment of HIV in the future such as long-acting formulations of ART and possible cures. This review highlights the role of further research and policy formulation, as well as global community, in the fight against HIV epidemic and enhancing health outcomes of the affected populations.

Keywords: HIV, epidemiology, prevention measures, 90-90-90 goals, drug resistance, ART, global health, PrEP, HIV vaccine.

How to cite this article:
Km Priyanka Singh, Rifat Siraj. Impact of HIV on Global Health: A Comprehensive Review of Epidemiology and Interventions. International Journal of Virus Studies. 2026; 03(01):-.
How to cite this URL:
Km Priyanka Singh, Rifat Siraj. Impact of HIV on Global Health: A Comprehensive Review of Epidemiology and Interventions. International Journal of Virus Studies. 2026; 03(01):-. Available from: https://journals.stmjournals.com/ijvs/article=2026/view=237727


References

1. Global AI. Update. Seizing the moment, tackling entrenched inequalities to end epidemics. Published online. 2020;384. 2. Phillips JA. HIV and Workers. Workplace Health & Safety. 2021 Nov;69(11):541-. 3. Kallings LO. The first postmodern pandemic: 25 years of HIV/ AIDS. J Intern Med. 2008 Mar;263(3):218-43. doi: 10.1111/j.1365-2796.2007.01910.x. Epub 2008 Jan 16. PMID: 18205765. 4. Keen PM. Improving the timely diagnosis of HIV among gay and other men who have sex with men (Doctoral dissertation, University of New South Wales (Australia)). 5. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, Tappero JW, Bukusi EA, Cohen CR, Katabira E, Ronald A. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England journal of medicine. 2012 Aug 2;367(5):399-410. 6. Katz JM, Klein J. HIV care and prevention: A growing challenge in the 21st century. Lancet. 2021;398(10296):2732–2743. doi:10.1016/S0140-6736(21)02185-2 7. Zhao J, Yang Y. Impact of HIV/AIDS on global public health: Current challenges and future perspectives. Glob Health J. 2020;19(3):56–64. doi:10.1016/j.glohj.2020.01.001 8. Perkins DL, Francis S. New approaches to the treatment of HIV. J Antimicrob Chemother. 2020;75(2):321–325. doi:10.1093/jac/dkz430 9. Gavilanes AD, Cortes MM. HIV prevention in key populations: A multi-faceted approach. J HIV AIDS Soc Serv. 2019;21(2):101–112. doi:10.1080/15381501.2019.1576115 10. Mills EJ, Cooper C. Challenges of scaling-up HIV treatment: The road to universal access. Lancet Infect Dis. 2020;20(4):352–358. doi:10.1016/S1473-3099(19)30576-3 11. Morrow AC, Green LA. Integrating HIV care into primary health settings. J Prim Care. 2021;12(5):14–23. doi:10.1177/2324271621990813 12. Bertagnolli A, Lippi D. HIV co-infection and its impact on treatment outcomes. HIV Med. 2018;17(7):604–610. doi:10.1111/hiv.12602 13. Harrington D, Peterson J. HIV and tuberculosis co-infection: A public health priority. Infect Dis Clin North Am. 2021;39(2):287–300. doi:10.1016/j.idc.2021.02.001 14. Avert. HIV and AIDS in Sub-Saharan Africa [Internet]. Brighton: Avert; 2020 [cited year if required]. Available from: https://www.avert.org/professionals/hiv-around-world/sub-saharan-africa 15. Martin D, Jenkins T. The future of HIV vaccines: What does the science say? Vaccine. 2019;37(40):5794–5802. doi:10.1016/j.vaccine.2019.06.037 16. Kumar P, Gupta R. HIV prevention in high-risk populations: Approaches and challenges. Indian J Public Health. 2020;64(1):4–9. doi:10.4103/ijph.ijph_120_19 17. Clarke L, Tan RL. The role of digital health technology in HIV prevention and management. Glob Health Action. 2019;12(1):1650090. doi:10.1080/16549716.2019.1650090 18. Giles M, Shaw MA. Emerging drug resistance in HIV treatment: Current understanding and clinical management. AIDS Res Ther. 2020;17(1):1–13. doi:10.1186/s12981-020-00268-3 19. Stone MS, Burke C. HIV testing and diagnosis: Tools for global health. J Clin Microbiol. 2021;59(2):e01234-20. doi:10.1128/JCM.01234-20 20. Fitzgerald J, Davis B. Global strategies for HIV vaccine research and development. Front Immunol. 2019;10:2513. doi:10.3389/fimmu.2019.02513 21. Auerbach JD, Kegeles SM. Behavioral interventions for HIV prevention: What works and what’s next? Am J Public Health. 2020;110(2):240–248. doi:10.2105/AJPH.2019.305337 22. Muthuswamy M, Mallick P. Addressing HIV stigma and discrimination in healthcare: Approaches and challenges. J HIV AIDS Soc Serv. 2020;22(3):141–155. doi:10.1080/15381501.2020.1739532 23. Lung A, Elias P. HIV care and prevention in high-risk populations: A review of strategies and interventions. Public Health Rev. 2021;42(1):1–15. doi:10.1186/s40985-021-00095-x 24. Pape JW, Boncy J. HIV prevention efforts in Haiti: Addressing a continuing epidemic. Am J Public Health. 2020;110(9):1250–1257. doi:10.2105/AJPH.2020.305761 25. Tang A, Zhao L. Technological advancements in HIV treatment: Impact on patient adherence and outcomes. J Med Technol. 2019;36(8):1123–1134. doi:10.1093/jmedtech/56.8.1123 26. Rosen S, Fox MP. Financial barriers to HIV care: Addressing access to ART. Glob Health Action. 2020;13(1):1787656. doi:10.1080/16549716.2020.1787656 27. Ncube K, Moyo J. ART adherence strategies in sub-Saharan Africa: A review of community-based interventions. Int J HIV AIDS. 2021;15:47–56. doi:10.1155/2021/5345760 28. Shannon K, Strathdee SA. HIV among women in conflict settings: Implications for policy and programming. Lancet Glob Health. 2021;9(8):e1090–e1097. doi:10.1016/S2214-109X(21)00213-5 29. Singh S, Tiwari M. HIV and the future of gene therapy: An overview. Gene Ther Regul. 2020;4(2):81–89. doi:10.1016/j.genreg.2020.02.006 30. Chang LW, Ali M. Global HIV/AIDS policies and their effectiveness: A critical review. Glob Health Policy Rev. 2021;34(3):201–213.

Ahead of Print Subscription Review Article
Volume 03
01
Received 05/02/2026
Accepted 05/02/2026
Published 20/02/2026
Publication Time 15 Days
54

Login


My IP

PlumX Metrics